COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status
ConclusionsPatients with decompensated cirrhosis in eastern China are largely remained at unvaccinated status, particularly those with previous episodes of ACLF or hepatic encephalopathy and liver transplantation recipients. Vaccination against COVID-19 in this population is safe.Graphical Abstract
Source: Infectious Diseases of Poverty - Category: Infectious Diseases Source Type: research
More News: Bleeding | China Health | Chronic Pain | Cirrhosis | Clinical Trials | Coronavirus | Covid Vaccine | COVID-19 | Gastroenterology | Infectious Diseases | Liver | Liver Transplant | Pain | SARS | Study | Transplants | Urology & Nephrology | Vaccines